Dr. KSS Posts from Biotech Showcase 2018, San Francisco
Dr. KSS will be reporting from the Biotech Showcase in San Francisco in the comments below. Enjoy!
Articles
Dispelling Certain Aurinia ($AUPH) Rumors
[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]
Is a Misperception Subduing Share Price at Aptose ($APTO)?
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He’s agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see his past articles and most recent comments here.] The death of Mr. Chiang, who was always kind, has never set well […]
Special Comment: Update from $ARTH CEO Terrence Norchi, MD, MBA
[Ed. Note: Dr. KSS writes about biotech and medicine for the Irregulars. He adheres to our trading restrictions, choses his own topics, and his words and opinions are his own. His past articles and most recent comments can be found at his Stock Gumshoe page.] Dr. Norchi called me at home this morning to provide […]
Aurinia R&D Day, New York City, October 20, 2017
Dr. KSS will be live blogging in the comments section below.
Tear Sheet: CohBar Inc. ($CWBR)
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
MicroCap Conference, Essex House, New York City, October 5, 2017
Dr. KSS will be live blogging from the conference in the comments below.
Oncotutorial
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
Long Idea of the Year
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his old articles and his most recent comments on his Stock Gumshoe page.] “Keep it quiet. (Go slow.) […]
Live Blog: Akari Therapeutics R & D Day, April 24, 2017
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his past articles and most recent comments on his Stock Gumshoe page.] On Monday, April 24, 2017, Dr. […]
The Conversation: ScyNexis ($SCYX) CFO Eric Francois
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics and his words and opinions are his own. You can see all of his past articles and most recent comments at his Stock Gumshoe page.] In June 2016, we advanced ScyNexis […]
Quickster: Update on Corbus
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. To see all of his column and his latest comments, go to his Stock Gumshoe page.] [Author’s note: This commentary has been […]
The Rest of the 12 Biotechs of Christmas
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Peaches come from a can They were put […]
The 12 Biotechs of Christmas: Six
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] Let’s turn our attention today, in a mild […]
The 12 Biotechs of Christmas: Five
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] Our fifth stock on this Christmas outing is […]
The 12 Biotechs of Christmas: Four
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] It’s a warm Sunday afternoon a few months […]
The Twelve Biotechs of Christmas: Three
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] Remember that British group with frontman Robert Smith? […]
The Twelve Biotechs of Christmas: Two
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] After the New Year, we plan to look […]
The Twelve Biotechs of Christmas: One
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] Ho ho ho! And Happy Christmas to all […]
The Conversation: Achaogen COO Blake Wise
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Elsewhere the sky is the roof of the […]
Such A Pleasant Stay
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Thanks to you I’m much obliged Such a […]
Sea of Tranquility
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “I live in the light of the bright summer […]
Tropic of Palatin
[Ed. Note: Dr. KSS writes about biotech and medicine for the Irregulars. He has agreed to our trading restrictions, chooses his own topics and his thoughts and opinions are his own. His previous columns and recent comments can be found on his Stock Gumshoe page.] “He had never seen her body so abandoned, so unconscious […]
Ten Common Biotech Investing Mistakes
[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]
Quickster: T2 Biosystems ($TTOO)
[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page to see his biography, latest comments and past articles.] About 18 months ago, I came across tiny Boston-area diagnostics start-up […]
Conflict Diamonds
[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and more recent comments here.] Picture the gurbling fumaroles of Yellowstone: from the late 1990’s and on into […]
The Postman Always Rings Nice: More Sophistry at Sophiris ($SPHS)
[Ed. Note: Dr. KSS is an MD, PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, he choses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe author page to see his past columns and most recent comments.] Readers have […]
An Open Letter to TransEnterix CEO Todd Pope, Esq.
[Ed. Note: Dr. KSS is an MD, PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, he choses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page to see his past columns and most recent comments.] Dear Mr. Pope: […]
Quickster: Introducing ScyNexis ($SCYX), a New Antimicrobial Play
We’ve palavered much over the past two years about investing in makers of novel antibiotics….and had success with our long ideas Durata (now a unit of Allergan $AGN) and CellCeutix ($CTIX). Achaogen ($AKAO) remains a stock we love, and we predict investor rewards there in due course. We all know the familiar mantras here: antibiotics drive […]
Quickster: The Long Case for Ignyta ($RXDX)
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He choses his own topics, has agreed to our trading restrictions, and his words and opinions are his own. You can see his past columns and most recent comments on his Stock Gumshoe page.] “Come on baby light my fire.” —- […]
Special Commentary: Turbulence for Esperion
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He choses his own topics, his words and opinions are his own, and he has agreed to our trading restrictions. You can see his Stock Gumshoe page here.] When I was an undergraduate student, I became a good friend of Michael D., […]
What Pliny Said
Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions and his words and opinions are his own. You can see his biography and past articles here. In the beginning, there was a canopy, verdant and succulent, given to inky-black nights punctuated by the utterances […]
Will February Bring a Swing Trade in Regulus ($RGLS)?
Everybody’s got to deviate from the norm. —Rush John Galsworthy wrote that the beginning and endings of human undertakings are untidy. It was never more so than in the early days of HCV, a mere 20 years ago, when a plague first called “non-A non-B hepatitis” began vexing people, progressively scarring their livers and behaving […]
Cyto Who?
[Ed. Note: Dr. KSS is an MD and PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and recent comments here.] You’re probably getting it right by now—writing “2016” and not “2015.” […]
Answers and Discussion: 2015 Annual Gumshoe Biotech Certification Examination
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics and his words and opinions are his own. Visit his Gumshoe page to see his articles, biography, and most recent comments]. Lots of you took the exam online (congratulations on how you did), while others took it […]
The Sophiris Boondoggle
A brief column, if I may, to capture the teachable moment offered to us by the release of 52-week data from Sophiris ($SPHS). Longer-term readers recall that we first introduced Sophiris as a long investment idea on 30 November 2014. The company had taken an unusual toxin, called aerolysin, from the freshwater bacteria Aeromonas that, when activated, […]
The Manchurian Candida
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and biography here.] “Many things you hear in this room are untrue.” (sign posted in Yale-New Haven Medical Center physician cafeteria) […]
Is Zafgen Kaput?
“It was like a teetering house of cards, A contortionist strumming a ukulele, A gorilla raging in someone’s attic, A car graveyard frantic to get back On the interstate highway in a tornado, Tolstoy’s beard in his mad old age, General Custer’s stuffed horse… What was? I ask myself and have no idea, But it’ll […]
The Postman Always Rings Nice
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can read his past articles, latest comments, and bio here.] We love when readers write in, and most of the questions, even though privately put, are […]
The Tao of Recro
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his past articles here.] “Who wants honey? As long as there’s some money?” —–“Cherub Rock,” Smashing Pumpkins, Siamese Dream (words and […]
An Auspicious Conversation with Aurinia CEO Stephen Zaruby
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and most recent comments here.] “Doctor doctor, what do you say, let’s put the id back in yid,” Portnoy groused to […]
CellCeutix: 23 Minutes with Leo Ehrlich
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here.] “All non-denial denials. They doubt our ancestry, but they don’t say the story isn’t accurate.” —-from All the President’s […]
BioDimSum III: Keep on Rockin’ in the Gummune
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his Stock Gumshoe page, with all of his past articles, here. Enjoy!] Welcome all! We’ll forego the food and beverages this time as many […]
The Second Coming of TransEnterix?
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his previous articles and most recent comments here.] Go on, admit it: you enjoyed that rambunctious little scene in Ridley Scott’s Prometheus […]
Cisco, Chang & Charlie, Part Two
[Dr. KSS writes about medicine and biotech stocks for the Irregulars. You can find his biography and previous columns here. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] Second of Three Parts Frederick Towne Melges, M.D. The name probably doesn’t stir the memory banks of Gumshoe readers. […]
A Biotech Long Idea Brought to You on Bended Knee
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics and his words and opinions are his own. He has agreed to our trading restrictions. You can see his previous articles here. Enjoy!] In 1970, splendid French filmmaker Erich Rohmer wrote and directed a nearly perfect flick: […]
Cisco, Chang & Charlie
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here. Enjoy!] Do you have quirky, enigmatic notions that hang with you? Douglas Hofstadter, writing in Godel, Escher and Bach: […]
Special Bulletin: The CoLucid IPO
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. You can see all of his articles archived here. Enjoy!] CoLucid Pharmaceuticals, which recently moved from Durham, NC, to Cambridge, MA, plans an initial public offering. Recent news suggests the […]
The Last Samurai Biotech
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. His bio, past articles, and most recent comments can be seen here. Enjoy!] OUT of the night that covers me, Black as the Pit from pole to pole, I thank […]
Abiding Ambiguity: Achaogen and Arrowhead
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He choses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Enjoy!] In his smoky baritone, singer Stuart Staples of British midlands musical act Tindersticks is bemoaning how he suspects the woman he […]
The Great Gallic Foie Gras Hack
“I firmly believe that if the whole materia medica could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.” — Oliver Wendell Holmes, M. D., Professor of Medicine , Harvard “With all his conscience and one eye askew, So false he […]
Primer on Drug Development
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, and his words and opinions are his own. This piece is for reference. You can see all of his articles here.] For biotech Irregulars, this is a concise overview of what goes on in each phase […]
Gumshoe BioDimSum II: Corralling the “A” Biotechs Plus a New Long Selection
[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]
Seven Reasons to Be in Flex Pharma ($FLKS)
[Ed. Note: This bonus note is by Dr. KSS, who writes about medicine and biotech stocks for our Irregulars. As with all our contributors, he chooses his own topics, and his words and opinions are his own. He has agreed to our trade restrictions. Discussion of this topic will continue under Dr. KSS’s latest full […]
The Zed Files
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] It could be the premise of a tawdry unrated movie that teenage boys sneak glimpses of on Netflix when they’re home alone. […]
Saving Jack Kerouac
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] His tidily rhyming names perhaps destined him for fame. While Jack Kerouac’s work and popularity were before my time, his cultural and literary restlessness assure him […]
Biotech Dim Sum: ARTH, CLDN, ESPR, BLRX, GILD and a New Baby Biotech for 2015
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. His previous columns can be found here. Enjoy!] Every New Year, a friend and I flew to Boston. She’d gone to medical school […]
Need to Know: Special Update on Achaogen
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions.] If you get infected with CRE in your blood, your lungs, your urine, or your biliary system, what is your chance of […]
Dawn of the Planet of the TLOGlodytes!
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]
Big Bucks from Big Prostates?
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] Readers not familiar with Stock Gumshoe usually arrive wondering if the salivation provoked by stock promotional writers for certain companies is justified. […]
Will This Unknown Boston Biotech Make Present Surgical Techniques Obsolete?
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. His topics, words and opinions are his own. Enjoy!] It’s the second reel of conspiracy film Shooter, and Mark Wahlberg, whom government schemers are trying to frame for assassination, has just been shot twice. In the back of a stolen FBI car, […]
Oxidation for Health…Physical and Fiscal
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]
A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]
Why Regado May be Oversold
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading rules and he chooses his own topics. His words and opinions are his own. Enjoy!] In June 1962, women working in the dressmaking arm of a certain American textile factory were overcome with fear. Rumors began […]
The Gain from Pain Mainly Explained (part one)
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading rules and he chooses his own topics. His words and opinions are his own. Enjoy!] Lying in bed beneath an exam lamp, my 16-year-old patient’s facial serenity belied how fervently he was kneading misbaha beads with […]
Yellow Eyes, White Powders, and an Unknown Nordic Biotech That May Green Things Up for Investors
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own. Enjoy!] In the Saturday morning Looney Tunes many of us saw as children, one trope always stuck with me: that of the grand piano falling from way up high and crashing, splintering itself. There’s a […]
Is This Red-Hot New “Blood Stock” Any Bloody Good as an Investment?
[Ed. Note: Dr. KSS writes about biotech stocks for the Irregulars. We have not reviewed or approved his topics or opinions, and he has agreed to our trade restrictions. Enjoy!] Twenty years ago, I was living life on an extreme slant as a medicine resident. My routine was a rut of working 36 hours, having […]
Of Needles, Haystacks, and the Needle-in-a-Haystack Cancer Diagnostics Nanocap That May Belong in Your Portfolio
[Ed. Note: Here is the latest from Dr. KSS, who writes about health, medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and ideas are his own.] Dedicated to Cynthia Chew Choon Hoon (1959-2013). In pace requiescat. Imagine a day down the hallway of the future. You’re […]
Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?
What’s the commonest reason for admission to hospital of people 65 and over? Mull that question, as it provides context. Think of people you know. At least one probably has this condition. It’s not diabetes. It’s not heart attacks. And it is not infectious. But it kills and lots of people have it. Part II […]
Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know)
[Ed. Note: Here is the latest contribution from Dr. KSS, who writes for the Irregulars about medicine and biomedical stocks. As always, he has agreed to our trading restrictions and his words and thoughts are his own.] The Belle of the Everglades How To Profit From The Cure First of Two Parts Of the many […]
Guaranteed Weight Loss without Surgery, Drugs or Dieting! (Really!)
A pre-emptive tease: no newsletters are yet touting this company, but like many stocks that they do tease, it is small, cheap, almost unknown, and even has the exotic appeal of being Australian. Sort of. At Stock Gumshoe we not only deconstruct pitched stocks, we find teasable stocks before the newsletters do! Let’s return to […]
Antibiotics Don’t Get No Respect, But You Can Still Profit From Them
[Ed. Note: Dr. KSS, formerly knowns as karmaswimswami on our discussion threads, is here again to talk to the Irregulars about health and medicine and biotech investing ideas. As with all of our guest contributors, he has agreed to our trading restrictions and we have not reviewed, approved or screened his stocks or ideas, and […]
In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
[ed note: Longtime commenter and reader Dr. KSS, a medical doctor and biotech investor, has agreed to share his thoughts with the Irregulars as one of our guest authors, educating us on health and medicine and sharing some of his biotech investing ideas. He has agreed to the same basic trading restrictions as other paid […]
NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It
[ed. note: Gumshoe readers have been delighted with the biotech stock discussion led by one of our readers, who has gone by the name karmaswimswami as he has shared hundreds of useful comments — so we’ve asked him to come on as a formal contributor, he’ll be sharing a column with the Irregulars and talking […]
Comments
Claude Please note that Dr KSS has left this building. He no longer reads or posts here. You responded to a note that...
beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSSbeat Dr KSS sugar diet topic as...
beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSSbeat Dr KSS sugar diet topic as...
beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSS...
beat Dr KSS sugar diet topic assignment ZKSS...
beat Dr KSS sugar diet...
$AFMD NP tanglewood - Thanks for saying when Dr KSS mentioned it as I had no recollection at all of the stock....
More on $AFMD. Dr KSS first mentioned it in 'The Rest of the 12 Biotechs of Christmas' published on Feb 9,2017. At the ...
Thank you Ben for that info. I am still long this stock when Dr KSS first recommended it. Cost basis $2.26 per share on ...
$AUPH - Actually, in my experience, Helen can be terrific on holding hands. And so I'm clear: I did not, and would not, ...
$AUPH - etc. Keep in mind Helen uses technicals as well as science. One reason I chose not to follow Dr. KSS also applie...
Dear Dr KSS -- Thanks very much for this insightful review of cancer and its treatment in mainstream medicine. Your com...
Thanks for sharing, Jerome. I inquired awhile back if anyone out there smarter than I (that really opens it up) had any ...
STM, I couldn't agree more. I think KSS did have great insight into the science that he shared freely (early on at least...
$ARTH New Theme: "Dr. KSS program to make Stock Gumshoe great again: Arbitrarily kick people out of Biopubkss" ...
$ARTH $CWBR STM To be honest I hope we can just be on one thread. Gets too confusing. Dr. Norchi is the most car...
#Cleveland Apology Glad you brought it up. I was thinking about it. I do apologize to you and Hippockets and all. I w...
Off topic a bit (though it is related to small biocaps), but do you Travis, or anyone else know what became of the Newsl...
Oh Oh; it looks like the cat is out of the bag! So sarah you are the famous Alan Harris from Dr. KSS biotech thread....
1. I don’t think that the SPLC is in any way a “terrorist organization.” 2. Lifetime memberships are non-refun...
$AKAO I think you hit the nail on the head STM. It would not surprise me if the FDA votes for approval for the BSI indic...
Plus...no Dr Kss for guidance on the medicine. I would not have gone into the sector at all without someone like him e...
The majority of money I have lost in the stock market has been due to following the advice of Dr. KSS so I for one will ...
$AUPH And then there was one..... As Dr. KSS predicted before he left, ImmuPharma's Lupuzor P3 for the treatment of Sy...
Why pray tell would anyone TD any of Ben's posts? What agenda would anyone have, sycophant or not, to derive pleasure ...
$CWBR, Are you saying that DR KSS and Cleveland have sold their shares?...
ptn $1.36 DR.KSS said he was still holding.That was about a year ago....
The new conference call with Dr KSS will be Friday 4/6 @ 12:30ET. Usual protocol - (712)770-4063 then 850326#. Callers w...
$Dr KSS Looks like I subscribed in time yesterday. Did it via PayPal to my bank acct. Sorry I broke the system. :(...
$DR. KSS $DR. Relentless THE NEW DR. KSS WEBSITE IS UP AND RUNNING!!! biopubkss.com...
SG Newsletters - FWIW - Many years ago, when I was grasping for valid information about biotech, and was a GS newbie, I ...
Frankly, Cleveland, if you will remember how hostile you were towards me, you might realize why I felt I could not have ...
Cleveland - I may be in the minority, which bothers me not at all, and I sincerely appreciate your comment(s). I've bee...
Does dr kss have a column or is the only access through twitter?...
I sold out when the market opened. Later I saw that Dr. KSS sold as well....
For those of you who were unable to participate in the conference call today with Dr. KSS and Processa Pharma, here is t...
# Conference Call Date Jim - I was simply replying to your post which stated, "A new conference call with Dr. KSS will ...
$APTO, ow - has been doing its own version of March Madness with CEO Rice (accompanied by CFO Chow) making presentations...
A new conference call with Dr. KSS will take place this Friday (10/23) at 12:30pm ET. The primary purpose is to showcase...
I'm out of $PTI. Dr. KSS spoke favorably of Julia S-S. Left with a modest profit....
$SNDX also out with nice profit! Thanks Dr KSS!...
$SRNE $VTGN - According to my notes, Dr. KSS said Sorrento went through a tumultuous time, but he thinks "they're go...
$RTTR For those who think institutions don't buy penny stocks....baker bros are long this one under 0.30 cents. Dr Kss ...
$SRNE np - Dr KSS on the call yesterday said 'to be cautious' with SRNE. He talked a bit about why, but I did not write...
Where do we find the List of the 12 Dr KSS stocks ?...
many thanks, Jim and Dr Kss....
$Ø Thanks for doing this Jim. As I'm not an active Twitter poster I hope someone will relay my thanks to Dr KSS for...
Comments copied from the biotech-discussion-continued thread on 3/8/18: vmsk33094 JoeS you wrote on 3/7/2018 that A...
$Conference Call 9.3.18 No this is a call which Dr KSS has referred to on Twitter. It looks as though he will be conduc...
$APTO Joe, Dr KSS said on 23.01.18 - "I predict that (lifting of clinical hold) will come during the 3rd week of Mar...
Here’s several comments about $APTO that were posted to the biotech-discussion-continued thread. ==================...
From https://www.stockgumshoe.com/2018/02/microblog-discussion-page-for-aurinia-pharmaceuticals-auph/ (a dedicated thre...
The $AUPH tab on the spreadsheet at http://tinyurl.com/KSSDAMAN has been updated with the latest comments from Dr. KSS....
$APTO long. This must be a significant milestone for Aptose. Dr. Rice and Greg Chow are presenting at 4 investor confe...
$Conference call with DR KSS Friday, March 9, at 12:30pm ET. To participate: Dial (712) 770-4063, and when prompted inpu...
I (Doc Gumshoe) am staying with Stock Gumshoe - who bailed was Dr KSS. I wish him good fortune. I'll be on this webs...
$FATE ow taxable, this company is so diverse and grown so quick I forgot why I was in it. Also $ARTH ow taxable, green, ...
Travis, you might be too young to remember Paul Harvey, an ABC radio personality in the late 1900s. He was famous for...
#CURT Thanks. I am no saint or qualified for President. I just happen to have met the person #DRKSS. Since 2015 I w...
$ARTH ow and biggest holding: Hi Cleveland, still glad you are here brother! This is my first post in a while as I h...
Would someone provide the Dr KSS conference call replay number. I missed the call and the announcement....
Cleveland - Do you know whether DR KSS is working on a new (service) site?...
Cleveland - I really miss your commentary. I've been a huge fan since you saved my tail w/$CLRBZ. I deeply regret ANY ...
Pgathua, Glad to tell you everything I know (which I'm afraid isn't much) but I'm not business oriented enough to do mea...
In Feb. of 2016, Dr. KSS indicated a lack of enthusiasm for $EDIT....
Both Dr KSS and Helen have recommended $DMCAF on Twitter; also Oncolytics....
$DMCAF - np (sadly) - Looks like the jump coincides with the Dr KSS tweet that he quadrupled his position in it. I wa...
If you missed the S&P run because of investing in biotech, you should really do yourself a favor and learn to diversify ...
porgie - I don't think many here followed Dr. KSS like sheep. With that said, his background is none of my business; I ...
Ben, Roger, STM, et al - I have been following two stocks for personal reasons as well as investments - $AVXS and $RGNX....
Anyone else here invested in $CORT or have an opinion on this company? Lately I've been reading the following blog - ht...
Hi Porgie. I owned $SNDX for a while as well but sold out once I took another look at the phase 2 data for E2112 - HR+, ...
There are plenty of intelligent people who post here. If you don't know who they are and aren't willing to read anything...
It's too bad, too. All these folks were very bright and added a lot to the discussion. Hard to believe they all had such...
Had a great day. Thank you Dr. KSS and Helen....
And he posted his hateful vile on the internet to gain emotional revenge on the good Doc. You forgot that part. Just pla...
$CYDY np - this is why it would be so nice if Dr. KSS were still with us. The release above sounds and reads like good ...
$Dr.KSS stock recommendations I have been following some of this and other recent biotech thread’s discussions on the ...
Does anyone know the twitter address for Dr KSS? Thanks in advance!!...
$CAPR np, DR KSS latest tweet: "They got the regenerative medicine nod from FDA they'd been seeking. I had honestly pred...
STM thanks for the update. From the stocks from your portfolio i have an observation and potential income earner. $CLRB...
Even knowing what I know now...I would still invest with Dr KSS but that information would have been nice to know. Blata...
Cleveland - I miss you, Doc, LinLing, et al. Those posting negatives about Dr. KSS, in my opinion, are shown to be cow...
The true facts are that Dr Kss is very knowledgeable and saved all of us from lots of pitfalls but he also harmed a lot ...
Mary...can I list all the neuro plays Dr Kss stubbornly advanced here ..even after being questioned a few times. $CUR be...
mzimmer wrote: "Same with $TTPH. It was supposed to have doubled. Just bombed today." DR KSS on $TTPH: "Don't be a su...
Cleveland - I am trying to negotiate Twitter and would like to follow you if you are on there - I found Helen and I thin...
Dr KSS is the best source on the science behind bios that I've come across. My big regret is only finding him a year or ...
We live in an age where people on the board of local public school systems routinely receive death threats. DR KSS may n...
Totally !! Shameful !! Richardo: "Regardless of what you think or have read about Dr. KSS, for someone to denigrat...
cleveland- any update on when/if Dr KSS will have a new site available? I suppose you could contact me through Travis if...
Why 3 thumbs down for Cleveland (well now it is only 2) Cleveland is an honorable,man who has worked his a** off for us...
#Pure Hypocrisy Trash Dr. KSS viciously trying to harm him emotionally and then you pitch one of his picks????? Path...
$apto ow Not sure if there's anyone left here who can weigh in. There was a discussion on twitter, someone posed a quest...
$APTO ow I'm goin' on Dr. KSS' recommendation on this one and looking for some catalysts in the upcoming months. As fa...
The reaction of Dr.Kss is good enough for me !!!...
Roger, I am glad that KSS has a loyal friend, but I find your confusing of character and intellect confounding. A spark...
Dr. KSS is no longer working with Stock Gumshoe, but he is available on Twitter if you want to follow up with him (@KSSM...
Hi. Can someone form Gummunity please post Dr KSS’ Monthly conference call number ? Been on here a while but have ne...